Compliance Rate
Compliance Rate
36.36%
Compliant submissions
8
Incompliant submissions
14
Total trials
22
My Organizations' Clinical Trials
Showing 800 of 1641 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/17
End: 06/07/21
Due: 06/07/22
Phase: N/A
Priority: Normal
Start: 08/10/20
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 04/17/18
End: 03/22/23
Due: 03/22/24
Phase: N/A
Priority: Normal
Start: 09/30/18
End: 07/31/21
Due: 07/31/22
Phase: N/A
Priority: Normal
Start: 08/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 11/27/18
End: 03/15/19
Due: 03/15/20
Phase: N/A
Priority: Normal
Start: 01/19/21
End: 12/22/21
Due: 12/22/22
Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 11/17/17
Due: 11/17/18
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 07/03/20
End: 07/08/20
Due: 07/08/21
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 07/31/10
Due: 07/31/11
Phase: N/A
Priority: Normal
Start: 06/24/23
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 02/07/23
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 01/31/18
Due: 01/31/19
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 11/30/21
Due: 11/30/22
Phase: N/A
Priority: Normal
Start: 12/12/18
End: 12/02/21
Due: 12/02/22
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 05/31/12
Due: 05/31/13